Physiological and pharmacological implications of beta-arrestin regulation
- 31 March 2009
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 121 (3), 285-293
- https://doi.org/10.1016/j.pharmthera.2008.11.005
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychoticsProceedings of the National Academy of Sciences of the United States of America, 2008
- β-Arrestins Regulate Atherosclerosis and Neointimal Hyperplasia by Controlling Smooth Muscle Cell Proliferation and MigrationCirculation Research, 2008
- Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2−/− miceBehavioural Pharmacology, 2008
- β‐Arrestins specifically constrain β2‐adrenergic receptor signaling and function in airway smooth muscleThe FASEB Journal, 2008
- Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivoProceedings of the National Academy of Sciences of the United States of America, 2008
- GPCR functional selectivity has therapeutic impactTrends in Pharmacological Sciences, 2007
- Physiological Roles of G Protein–Coupled Receptor Kinases and ArrestinsAnnual Review of Physiology, 2007
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor ActivationOnline Journal of Public Health Informatics, 1997
- Discriminative stimulus properties of the serotonergic agent 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)Life Sciences, 1986